Influence of Corynebacterium parvum-per on disease progression in the NZB/W model of systemic lupus erythematosus
- 1 January 1992
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 14 (1), 35-41
- https://doi.org/10.1016/0192-0561(92)90102-q
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 miceClinical Immunology and Immunopathology, 1989
- The Biological Response Modifier OK-432 (a Streptococcal Preparation) Inhibits the Development of Autoimmune Kidney Disease in NZB/W F1 Hybrid Mice: Possible Involvement of Tumor Necrosis FactorInternational Archives of Allergy and Immunology, 1989
- Tumour necrosis factor-α in murine autoimmune 'lupus' nephritisNature, 1988
- In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.The Journal of Experimental Medicine, 1987
- Steroids and tuftsin fail to prevent the induction of altered plasma proteinase homeostasis in mice bearing the B16 melanoma or treated with C. ParvumInternational Journal of Immunopharmacology, 1987
- BCG, in Contrast to C. parvum, Does Not Induce Increased Sensitivity to the Toxic Effects of Indomethacin in MiceJournal of Leukocyte Biology, 1986
- Studies of Peritoneal Macrophage Function in Murine Systemic Lupus Erythematosus. 2. Nature of Elevated Resident Peritoneal Cells in NZB and (NZB × NZW)F1 MiceJournal of Leukocyte Biology, 1985
- Murine Models of Systemic Lupus ErythematosusAdvances in Immunology, 1985
- Treatment Of NZB/NZW F1 Hybrid Mice with Mycobacterium Bovis Strain BCG or Type II Interferon Preparations Accelerates Autoimmune DiseaseArthritis & Rheumatism, 1981